Search

everythinglearnresearchcommunity

for

Search:↓

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Lupus can look like hair loss from alopecia areata but needs different treatment.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

A patient with patchy hair loss was successfully treated for Tumid Lupus Erythematosus after other treatments failed.

EMS and EF both show similar skin and fascia changes, but EMS has more severe symptoms and nerve inflammation.

Dogs with dermatomyositis, especially Collies and Shetland Sheepdogs, need better treatments for their skin and muscle inflammation.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Neomycin is a common cause of follicular contact dermatitis, which is treated by avoiding the allergen and using creams.

Avoiding allergens can improve skin and hair conditions in adults with allergic reactions.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

The review emphasizes the need to recognize skin conditions that affect hair follicles and sweat glands to avoid misdiagnosis.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

Toxic Shock Syndrome cases increased due to new factors, but decreased with public health measures and changes in tampon use.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Trichotillomania, a disorder where people compulsively pull out their own hair, often starts around age 12, is more common in adult females, and can be treated with behavior therapy and medication.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

Careful management of blood thinners is crucial for lupus patients with APS.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.